58 related articles for article (PubMed ID: 22623208)
1. Modeling and simulation approaches to evaluate pharmacokinetic sampling contamination from central venous catheters in pediatric pharmacokinetic studies of actinomycin-D: a report from the children's oncology group.
Edwards AY; Skolnik JM; Dombrowsky E; Patel D; Barrett JS
Cancer Chemother Pharmacol; 2012 Jul; 70(1):83-94. PubMed ID: 22623208
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the indotecan-neutropenia relationship in patients with solid tumors by population pharmacokinetic modeling and sigmoidal E
Beumer JH; Kennard BC; Holleran JL; Moore N; Zlott J; Miller BM; Kummar S; Chen A; Doroshow J; Park W; Gobburu J; Dunn A
Cancer Chemother Pharmacol; 2023 Mar; 91(3):219-230. PubMed ID: 36813886
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic analyses for BC-3781 using phase 2 data from patients with acute bacterial skin and skin structure infections.
Rubino CM; Xue B; Bhavnani SM; Prince WT; Ivezic-Schoenfeld Z; Wicha WW; Ambrose PG
Antimicrob Agents Chemother; 2015 Jan; 59(1):282-8. PubMed ID: 25348519
[TBL] [Abstract][Full Text] [Related]
4. A pharmacokinetic model for amiodarone in infants developed from an opportunistic sampling trial and published literature data.
Dallefeld SH; Atz AM; Yogev R; Sullivan JE; Al-Uzri A; Mendley SR; Laughon M; Hornik CP; Melloni C; Harper B; Lewandowski A; Mitchell J; Wu H; Green TP; Cohen-Wolkowiez M
J Pharmacokinet Pharmacodyn; 2018 Jun; 45(3):419-430. PubMed ID: 29435949
[TBL] [Abstract][Full Text] [Related]
5. A population pharmacokinetic model of methotrexate in Korean patients with haematologic malignancy.
Jung YS; Son M; Lee SG; Chong JW; Kim SJ; Jang JE; Lyu CJ; Hahn SM; Han JW; Park K
Br J Clin Pharmacol; 2024 Mar; 90(3):849-862. PubMed ID: 37984417
[TBL] [Abstract][Full Text] [Related]
6. Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model.
Dvořáčková E; Šíma M; Zajacová A; Vyskočilová K; Kotowski T; Dunovská K; Klapková E; Havlín J; Lischke R; Slanař O
Antibiotics (Basel); 2023 Sep; 12(9):. PubMed ID: 37760696
[TBL] [Abstract][Full Text] [Related]
7. Using real-world data to inform dosing strategies of rituximab for pediatric patients with frequent-relapsing or steroid-dependent nephrotic syndrome: a prospective pharmacokinetic-pharmacodynamic study.
Chen Y; Shen Q; Xiong Y; Dong M; Xu H; Li Z
Front Pharmacol; 2023; 14():1319744. PubMed ID: 38264525
[No Abstract] [Full Text] [Related]
8. Population Pharmacokinetics of Intramuscular and Intravenous Ketamine in Children.
Hornik CP; Gonzalez D; van den Anker J; Atz AM; Yogev R; Poindexter BB; Ng KC; Delmore P; Harper BL; Melloni C; Lewandowski A; Gelber C; Cohen-Wolkowiez M; Lee JH;
J Clin Pharmacol; 2018 Aug; 58(8):1092-1104. PubMed ID: 29677389
[TBL] [Abstract][Full Text] [Related]
9. Population Pharmacokinetics and Individualized Medication of Azithromycin for Injection in Children Under 6 Years Old.
Zhang Y; Wang Y; Li J; Wang H; Hou M; Dong R; Li X
J Pharm Sci; 2024 May; 113(5):1351-1358. PubMed ID: 38253224
[TBL] [Abstract][Full Text] [Related]
10. Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis.
Centanni M; van de Velde ME; Uittenboogaard A; Kaspers GJL; Karlsson MO; Friberg LE
Clin Pharmacokinet; 2024 Feb; 63(2):197-209. PubMed ID: 38141094
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic analyses of methotrexate in pediatric patients: a systematic review.
Cheng Y; Zhang Y; Zhang Y; Liu M; Zhao L
Eur J Clin Pharmacol; 2024 Jul; 80(7):965-982. PubMed ID: 38498098
[TBL] [Abstract][Full Text] [Related]
12. Population Pharmacokinetics of Doxycycline in Children.
Thompson EJ; Wu H; Melloni C; Balevic S; Sullivan JE; Laughon M; Clark KM; Kalra R; Mendley S; Payne EH; Erinjeri J; Gelber CE; Harper B; Cohen-Wolkowiez M; Hornik CP;
Antimicrob Agents Chemother; 2019 Sep; 63(12):. PubMed ID: 31548185
[TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetics of Atorvastatin in High-Altitude and Plain Patients with Hyperlipidemic.
Li Y; Huang Q; Zeng X; Wang R; Li W
J Clin Pharmacol; 2024 Mar; 64(3):345-352. PubMed ID: 37864509
[TBL] [Abstract][Full Text] [Related]
14. Application of Pharmacometrics in Pharmacotherapy: Open-Source Software for Vancomycin Therapeutic Drug Management.
Bae SH; Yim DS; Lee H; Park AR; Kwon JE; Sumiko H; Han S
Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31075931
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic modeling to facilitate dose selection of tapentadol in the pediatric population.
Watson E; Khandelwal A; Freijer J; van den Anker J; Lefeber C; Eerdekens M
J Pain Res; 2019; 12():2835-2850. PubMed ID: 31686902
[TBL] [Abstract][Full Text] [Related]
16. How to handle a missed or delayed dose of lacosamide in pediatric patients with epilepsy? a mode-informed individual dosing.
Wang J; Mei Y; Liang S; Li SC; Chen C; Nie G; Tuo YL; Sun D; Wang Y
Epilepsy Behav; 2024 Feb; 151():109601. PubMed ID: 38194771
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetic modeling of sotatercept in healthy participants and patients with pulmonary arterial hypertension.
Ait-Oudhia S; Jaworowicz D; Hu Z; Bihorel S; Hu S; Balasubrahmanyam B; Mistry B; de Oliveira Pena J; Wenning L; Gheyas F
CPT Pharmacometrics Syst Pharmacol; 2024 May; ():. PubMed ID: 38812074
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of oral spironolactone in infants up to 2 years of age.
Lass J; Leroux S; Kõrgvee LT; Varendi H; Kipper K; Takkis K; Aro R; Metsvaht T; Oselin K; Pfister M; Soeorg H; van den Anker J; Lutsar I
Eur J Clin Pharmacol; 2024 Feb; 80(2):239-248. PubMed ID: 38041740
[TBL] [Abstract][Full Text] [Related]
19. Guiding Dyslipidemia Treatment: A Population Pharmacokinetic-Pharmacodynamic Framework for Obicetrapib.
Dunn A; Ditmarsch M; Kastelein JJP; Kling D; Neild A; Davidson MH; Gobburu J
J Clin Pharmacol; 2024 May; ():. PubMed ID: 38720593
[TBL] [Abstract][Full Text] [Related]
20. Optimizing the design of a pharmacokinetic trial to evaluate the dosing scheme of a novel tuberculosis drug in children living with or without HIV.
Montepiedra G; Svensson EM; Wong WK; Hooker AC
CPT Pharmacometrics Syst Pharmacol; 2024 Feb; 13(2):270-280. PubMed ID: 37946698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
